APHL’s Newborn Screening and Genetics in Public Health Program strengthens the role of public health laboratories in genetics testing and designs strategies to address changes in the newborn screening testing field. The program proactively develops and recommends positions statements related to newborn screening and genetics to the Association. The program also provides input to the Newborn Screening Quality Assurance Program on quality control and proficiency testing issues relevant to newborn screening laboratories across the globe. The program interacts with state, federal and association partners in implementing national recommendations on newborn screening and genetics testing by participating on national and federal committees.
As states adopt new tests for additional diseases, APHL will continue to work with the Centers for Disease Control and Prevention to broaden our services to ensure the quality of test results and continuity of testing during an emergency.